InvestorsHub Logo
Followers 67
Posts 1297
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Thursday, 05/23/2019 10:26:54 AM

Thursday, May 23, 2019 10:26:54 AM

Post# of 703787
Today the Real-Time Level 2 Quote of OTC Market/NWBO is not working, a rare occasion as I have watched it almost daily:

https://www.otcmarkets.com/stock/NWBO/quote

People should have all known when we talk about the wolfpack, or evil short, we refer it to naked short, despite "the innocent" citation of the legal or registered short interests cited by those posters who are definitely the ones may well be involved in the naked short. Strange? Absolutely No.

One should understand this even if there are no separations between the main groups of patients in the trial, as long as the trial shows a long and thick tail as we know from unblinded data release, trust me the company via brilliant intelligent UCLA Dr. Liau's team will be able to prove it is DCVax-L that chiefly contributes to that long and thick tail, via various medical and analysis tools and immune data.

One also should have understand now if DCVax-L is approved by FDA alone, a market cap of at least $5 billion should be readily reached in short period of time, which is equivalent to about $5 ~ 6 per share on fully dilute base, excluding other indications, and DCVax-D, although in reality, I expect much more than that.

THERE WILL BE NO CHEAP SHARES, LET ALONE CHEAPER SHARES!

[When positive data are announced, the overwhelming majority of shares will be locked up, and shorts will forever remember that moment of hell they well deserve.]
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News